Journal of Pharmaceutical and Biomedical Analysis

The Journal of Pharmaceutical and Biomedical Analysis is an international, peer-reviewed journal published by Elsevier that applies analytical chemistry to pharmaceutical and biomedical science, founded in 1983, with a 2025 impact factor of 3.4（Journal of Pharmaceutical and Biomedical Analysis）是由 Elsevier 出版的国际化同行评审期刊，将分析化学应用于药学与生物医学，1983 年创刊，2025 年影响因子为 3.4。

Scope

• Development and validation of analytical methods, instrumentation, computation and interpretation across the pharmaceutical, biomedical and clinical sciences跨药学、生物医学与临床科学的分析方法开发与验证、仪器、计算与数据解读。
• Quantification of active pharmaceutical ingredients and excipients, together with drug purity and stability studies that include structure elucidation of impurities and degradants原料药与辅料的定量，以及包含杂质与降解产物结构解析的药物纯度与稳定性研究。
• Pharmacokinetics, therapeutic drug monitoring and metabolic profiling, plus drug-related analytical biochemistry and forensic toxicology药代动力学、治疗药物监测与代谢谱，以及药物相关的分析生物化学与法医毒理学。
• Quality assurance in the pharmaceutical industry and bioanalytical work on pharmacokinetics, bioequivalence and protein or DNA binding where the focus is on innovative methodology制药工业的质量保证，以及聚焦创新方法学的药代动力学、生物等效性与蛋白质或 DNA 结合等生物分析工作。
• Studies of traditional folk medicines are considered only when the analytical approach is innovative, and routine UV-VIS spectrophotometry, simple electroanalytical, fluorimetric and flow-injection methods are accepted only in exceptional cases传统民族药物研究仅在其分析方法具创新性时考虑，常规 UV-VIS 分光光度法、简易电分析、荧光与流动注射法仅例外接收。

History

• It was established in 1983 by Elsevier as a medium for academic, clinical, governmental and industrial analysis该刊 1983 年由 Elsevier 创办，面向学术、临床、政府与工业界的分析需求。
• It is published semimonthly, appearing twenty-four times a year该刊以半月刊形式出版，每年发行二十四期。
• As an international journal it draws its authors and editors from academia, industry and regulatory bodies, and it asks authors to compare their methods with previously reported ones作为国际化期刊，其作者与编辑来自学术界、工业界与监管机构，并要求作者将所提方法与既往报道的方法作比较。
• It had a 2025 impact factor of 3.4 and is indexed in the Science Citation Index该刊 2025 年影响因子为 3.4，被科学引文索引收录。

Editors

• The editor-in-chief is Bezhan Chankvetadze of Ivane Javakhishvili Tbilisi State University, whose interests include chirality, enantioseparations, high-performance liquid chromatography and capillary electrochromatography现任主编为（Ivane Javakhishvili Tbilisi State University）的 Bezhan Chankvetadze，研究领域涵盖手性、对映体分离、高效液相色谱与毛细管电色谱。
• The editors include Anderson De Oliveira, Sandra Furlanetto, Markus Ganzera, Kenji Hamase, Zhengjin Jiang, Michal Markuszewski and Sibel Ozkan编辑团队包括 Anderson De Oliveira、Sandra Furlanetto、Markus Ganzera、Kenji Hamase、Zhengjin Jiang、Michał Markuszewski 与 Sibel Ozkan。
• The editorial board has about fifty members from twenty countries, led by China and Italy with eight members each编委会约五十人，来自二十个国家，以中国与意大利人数最多，各八人。
• Manuscripts are peer reviewed, with particular scrutiny on novelty and significance and on how a proposed methodology compares with existing methods稿件经同行评审，尤其审视研究的新颖性与重要性，以及所提方法与现有方法相比的优劣。